Study Summary
This trial will compare a mindfulness-based insomnia treatment to sleep education in people undergoing stem cell transplants for multiple myeloma.
Eligible Conditions
- Multiple Myeloma
- Sleep
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 0 Secondary · Reporting Duration: 100 days after transplant procedure
Day 100
Number of Participants Completing Study Procedures
Up to 2 weeks
Number of Participants Enrolling in the Study
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Sleep Health Education
1 of 2
Mindfulness Awareness Practices for Insomnia
1 of 2
Active Control
Experimental Treatment
60 Total Participants · 2 Treatment Groups
Primary Treatment: Mindfulness Awareness Practices for Insomnia · No Placebo Group · N/A
Mindfulness Awareness Practices for Insomnia
Behavioral
Experimental Group · 1 Intervention: Mindfulness Awareness Practices for Insomnia · Intervention Types: BehavioralSleep Health Education
Behavioral
ActiveComparator Group · 1 Intervention: Sleep Health Information · Intervention Types: BehavioralTrial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 100 days after transplant procedure
Who is running the clinical trial?
Medical College of WisconsinLead Sponsor
561 Previous Clinical Trials
1,153,232 Total Patients Enrolled
14 Trials studying Multiple Myeloma
1,189 Patients Enrolled for Multiple Myeloma
Jennifer Knight, MDPrincipal InvestigatorMedical College of Wisconsin
3 Previous Clinical Trials
85 Total Patients Enrolled
1 Trials studying Multiple Myeloma
25 Patients Enrolled for Multiple Myeloma
Eligibility Criteria
Age 18+ · All Participants · 9 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You are eligible to receive melphalan 200 mg/m2 as conditioning regimen.
You are 18 years of age or older.
You must give voluntary written consent before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care.
You have been on systemic therapy for at least one year.
You are agreeable to random assignment and data collection, including survey completion and blood draws.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments